• Suppliers
  • External Access
Shareholders

Analyst Recommendations

Broker Update date Recommendation Target Price
Alantra Equities 25/02/2021 Buy 5.95€
Bankinter 06/11/2020 Hold 3.30€
Barclays 04/11/2020 Sell 2.50€
Bestinver Securities 14/10/2020 Buy 4.20€
CaixaBank BPI 11/02/2021 Buy 5.70€
Deutsche Bank 22/01/2021 Hold 4.50€
Exane BNP Paribas 25/02/2021 Buy 5.50€
GVC Gaesco 30/10/2020 Buy 4.00€
Intermoney Valores 22/12/2020 Buy 4.60€
JB Capital Markets 10/02/2021 Hold 4.40€
J.P. Morgan 05/01/2021 Hold 4.00€
Kepler Cheuvreux 25/02/2021 Hold 4.50€
Mirabaud 25/02/2021 Buy 4.84€
Morgan Stanley 23/11/2020 Buy 3.80€
Norbolsa 25/02/2021 Hold 4.74€
Oddo BHF 25/02/2021 Hold 4.50€
Renta 4 16/12/2020 Hold 3.74€
Santander 25/06/2020 Hold 2,93€
UBS 03/02/2021 Buy 4.30€
 


Disclaimer
 

“Gestamp is covered by the analyst firms detailed on this list. This list may not be exhaustive and is also subject to change. It should be noted that any opinion, estimate, or prediction in relation to Gestamp's performance made by the analysts of these companies are exclusively theirs and do not represent the opinions, estimates, or predictions of Gestampl or its management. The fact that it is included on this list or that this information is provided does not imply—and therefore expressly rejects—any type of endorsement or ratification of any type of information, estimate, prediction, or opinion of these analysts. This data—which falls outside of the scope of the mandatory information required by the Spanish National Securities Market Commission—is provided courtesy of the Company due to its utility and for purely informative purposes, and the Company has no intention of endorsing or providing any type of investment-related assessment. Gestamp does not guarantee and has not adopted any measures to verify the accuracy, suitability, or exhaustiveness of the data, and under no circumstance does it assume responsibility for any inaccuracy, omission, or error in this data; in the conclusions drawn therefrom; or for any decision made on the basis of this data or information.
 

The interpretations, estimates, opinions, forecasts, predictions, price targets, hypotheses, conclusions and recommendations, in addition to any non-factual information related to Gestamp's performance analyzed by the Analysts, are exclusively theirs and, therefore, do not represent the interpretations, estimates, opinions, forecasts, predictions, price targets, hypotheses, conclusions, or recommendations of Gestamp or any of its directors or employees. The publication of this list or of information on Analyst coverage, including the estimated results consensus, does not imply any type of endorsement or ratification by Gestamp of the interpretations, estimates, opinions, forecasts, predictions, price targets, hypotheses, conclusions and recommendations of the Analysts. Gestamp does not guarantee and has not adopted any measure to verify the accuracy, suitability, or exhaustiveness of this information, and under no circumstance does it assume responsibility for any inaccuracies, omissions, or errors contained therein; conclusions drawn therefrom; or any decision made based this information. This declaration also applies to the Analysts' obligation to document all circumstances that could reasonably jeopardize the objectivity of their recommendations and, in particular, all the relevant financial interests in the financial securities and instruments that constitute the object of the recommendation or conflicts of interest with the issuer to which the recommendation makes reference.”
 

Investor Relations Contact

Alfonso XII, 16 28014 Madrid